Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

NCT05710679 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT05710679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05710679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
Lead sponsor
Centre Jean Perrin
Phase
Not applicable
Overall status
Recruiting
Start date
January 17, 2024
Completion date
July 31, 2031
Enrollment
63 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced head and neck carcinoma